VANDA PHARMACEUTICALS INC (VNDA) Forecast, Price Target & Analyst Ratings

NASDAQ:VNDAUS9216591084

Current stock price

7.12 USD
-0.13 (-1.79%)
At close:
7.12 USD
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for VANDA PHARMACEUTICALS INC (VNDA).

Forecast Snapshot

Consensus Price Target

Price Target
$14.41
+ 102.35% Upside

Next Earnings Forecast

Earnings Estimate
Release Date
May 5, 2026
Period
Q1 / 2026
EPS Estimate
-$0.73
Revenue Estimate
56.143M

ChartMill Buy Consensus

Rating
80.00%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
$14.41
Upside
+ 102.35%
From current price of $7.12 to mean target of $14.41, Based on 10 analyst forecasts
Low
$7.58
Median
$12.75
High
$25.20

Price Target Revisions

1 Month
3.67%
3 Months
20.21%

Price Target Summary

10 Wall Street analysts provided a forecast for the next 12 months for VNDA. The average price target is 14.41 USD. This implies a price increase of 102.35% is expected in the next year compared to the current price of 7.12.
The average price target has been revised upward by 20.21% in the past 3 months.

Analyst Ratings & History

Current Analyst Ratings

VNDA Current Analyst RatingVNDA Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4 5

Analyst Ratings History

VNDA Historical Analyst RatingsVNDA Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8

Analyst Ratings Consensus

ChartMill Buy Consensus
80.00%
VNDA was analyzed by 10 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about VNDA.
In the previous month the buy percentage consensus was at a similar level.
VNDA was analyzed by 10 analysts. More opinions would make the average more meaningful.

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-05Truist SecuritiesInitiate Buy
2026-02-23HC Wainwright & Co.Maintains Buy -> Buy
2026-01-05HC Wainwright & Co.Maintains Buy -> Buy
2025-12-31B. Riley SecuritiesMaintains Buy -> Buy
2025-12-31JefferiesMaintains Hold -> Hold
2025-11-19HC Wainwright & Co.Reiterate Buy -> Buy
2025-11-05B. Riley SecuritiesInitiate Buy
2025-10-30Cantor FitzgeraldMaintains Overweight -> Overweight
2025-08-21HC Wainwright & Co.Reiterate Buy -> Buy
2025-05-07HC Wainwright & Co.Reiterate Buy -> Buy
2025-04-01HC Wainwright & Co.Reiterate Buy -> Buy
2025-02-18HC Wainwright & Co.Maintains Buy -> Buy
2025-02-04HC Wainwright & Co.Reiterate Buy -> Buy
2025-01-28HC Wainwright & Co.Reiterate Buy -> Buy
2025-01-21HC Wainwright & Co.Reiterate Buy -> Buy
2024-12-23HC Wainwright & Co.Reiterate Buy -> Buy
2024-10-31HC Wainwright & Co.Initiate Buy
2024-08-01Cantor FitzgeraldMaintains Overweight -> Overweight
2024-07-11Cantor FitzgeraldInitiate Overweight
2022-02-25JefferiesDowngrade Buy -> Hold
2021-05-12B of A SecuritiesInitiate Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 5, 2026
Period
Q1 / 2026
EPS Estimate
-$0.73
Revenue Estimate
56.143M
Revenue Q2Q
12.19%
EPS Q2Q
-45.86%
Number of Analysts
7

Next Earnings Revisions

Revenue (1 Month)
-0.94%
Revenue (3 Months)
-10.45%
EPS (1 Month)
-11.14%
EPS (3 Months)
-67.58%

Next Earnings Summary

VNDA is expected to report earnings on 5/5/2026. The consensus EPS estimate for the next earnings is -0.73 USD and the consensus revenue estimate is 56.14M USD.
The next earnings revenue estimate has been revised downward by 10.45% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.

Full Analyst Estimates 2026 - 2030

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
VNDA revenue by date.VNDA revenue by date.
192.64M
-24.28%
198.772M
3.18%
216.105M
8.72%
262.25M
21.35%
360.34M
37.40%
457.88M
27.07%
215.22M
-53.00%
197.88M
-8.06%
EBITDA
YoY % growth
VNDA ebitda by date.VNDA ebitda by date.
-10.942M
-221.58%
-32.528M
-197.28%
-140.948M
-333.31%
12.138M
108.61%
N/AN/AN/AN/A
EBIT
YoY % growth
VNDA ebit by date.VNDA ebit by date.
-13.952M
-321.46%
-40.66M
-191.43%
-151.168M
-271.79%
-152.528M
-0.90%
-63.447M
58.40%
5.916M
109.32%
-43.86M
-841.38%
-64.26M
-46.51%
Operating Margin
VNDA operating margin by date.VNDA operating margin by date.
-7.24%-20.46%-69.95%-58.16%-17.61%1.29%-20.38%-32.47%
EPS
YoY % growth
VNDA eps by date.VNDA eps by date.
0.05
-58.33%
-0.32
-740.00%
-1.80
-462.50%
-2.51
-39.40%
-0.77
69.38%
0.04
105.75%
N/AN/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-0.73
-45.86%
-0.61
-32.31%
-0.32
15.00%
-0.33
28.31%
Revenue
Q2Q % growth
56.143M
12.19%
62.552M
18.94%
73.134M
30.00%
75.208M
31.45%
EBITDA
Q2Q % growth
N/AN/AN/AN/A
EBIT
Q2Q % growth
-49.683M
-21.10%
-38.94M
-1.14%
-31.518M
-0.75%
-33.609M
16.71%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

VNDA Yearly Revenue VS EstimatesVNDA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M 400M
VNDA Yearly EPS VS EstimatesVNDA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 -1 2 -2

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
26.51%
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
27.17%
Revenue Next 5 Year
-2.33%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A

VANDA PHARMACEUTICALS INC / VNDA Forecast FAQ

What is the average price target for VANDA PHARMACEUTICALS INC (VNDA) stock?

10 analysts have analysed VNDA and the average price target is 14.41 USD. This implies a price increase of 102.35% is expected in the next year compared to the current price of 7.12.

When does VANDA PHARMACEUTICALS INC (VNDA) report earnings?

VANDA PHARMACEUTICALS INC (VNDA) will report earnings on 2026-05-05.

What are the consensus estimates for VNDA stock next earnings?

The consensus EPS estimate for the next earnings of VANDA PHARMACEUTICALS INC (VNDA) is -0.73 USD and the consensus revenue estimate is 56.14M USD.

What is the consensus rating for VNDA stock?

The consensus rating for VANDA PHARMACEUTICALS INC (VNDA) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.